Exagen Inc. XGN
Super Investor & Insider
1
Fondi che lo detengono
#1448
Rank consenso
1.4%
% dei portafogli
$375,726
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| First Eagle Investment Management · First Eagle Investment Management | 0% | Buy | 125,242 | $375,726 |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Exagen Inc. is a commercial-stage diagnostics company specializing in autoimmune testing solutions under the AVISE brand in the United States. It designs, develops, and commercializes testing products that enable healthcare providers to diagnose, prognose, and monitor complex rheumatic and autoimmune diseases, such as …
SectorHealthcare
ExchangeNASDAQ
IndustryDiagnostics & Research
CountryUnited States
Employees209
TickerXGN
Statistics
Market Cap$106.7M
Revenue (TTM)$66.6M
Net Income-$20.0M
Net Margin-30.0%
EPS$-0.93
P/E-5.02
P/S1.58
P/B7.48
EV/EBITDA-9.02
ROE-193.6%
Dividend Yield—
Price$4.43
Data: Twelve Data · Revenue = mcap / P/S